Form D · Biotechnology
Cryoport, Inc.
San Diego, CA · CIK 1124524
Offering snapshot reported May 25, 2012 · SEC filing
- Reported sold
- $5.21M Offering amount: $5.21M
- Investors reported
- 83 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 22, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 25, 2012 | Initial | $5,212,655 | No comparison | 83 | SEC filing |
| Feb 24, 2011 | Initial | $9,353,462 | No comparison | 131 | SEC filing |
| Oct 28, 2010 | Amendment | $3,872,702 | $583,001vs Sep 8, 2010 | 60 | SEC filing |
| Sep 8, 2010 | Initial | $3,289,701 | No comparison | 44 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $450K
- Finders' fees
- $0
- Form D file number
- 021-178851
Craig-Hallum Capital LLC received a warrant to purchase 189,551 shares of common stock; exercise price of $0.69 per share. Emergent Financial Group received a warrant to purchase 58,824 shares of common stock; exercise price of $0.69 per share.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Craig-Hallum Capital Group LLC | None | N/A |
| Emergent Financial Group, Inc. | 37891 | N/A |
| Maxim Group LLC | None | N/A |
Source: Form D, filed May 25, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Bonde | Director |
| Catherine Doll | Executive |
| Carlton M. Johnson | Director |
| Adam M. Michelin | Director |
| Karen M. Muller | Director |
| Larry G. Stambaugh | Director, Executive |
| Robert G. Stefanovich | Executive |
| Stephen Wasserman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
225 Broadway, Suite 430
San Diego, CA, 92101
San Diego, CA, 92101